Vaccinex, Inc.
VCNX· OTC
VCNXVaccinex, Inc.
Filed May 15, 2019 · 10-Q · 45 days after period end · 0001564590-19-019256
| Metric | Q1 2019 | Q1 2018 |
|---|---|---|
| Revenue | $94.00K | $206.00K |
| Net Income | -$9.07M | -$7.86M |
| EPS Diluted | -$0.79 | -$7.13 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Vaccinex, Inc. · CIK 1205922 · Engraved from SEC EDGAR
ended Mar 31, 2019 · filed May 15, 2019 · 45 d after period end
